ChemSpider 2D Image | DU2200000 | C10H16ClN5

DU2200000

  • Molecular FormulaC10H16ClN5
  • Average mass241.721 Da
  • Monoisotopic mass241.109421 Da
  • ChemSpider ID12708

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1-(2-Phenylethyl)biguanide hydrochloride
1,1-Benzylmethylbiguanide hydrochloride
1-Fenetilbiguanide cloridrato [Italian]
212-637-3 [EINECS]
834-28-6 [RN]
DBI monohydrochloride
Diamide N-(2-phényléthyl)imidodicarbonimidique, chlorhydrate (1:1) [French] [ACD/IUPAC Name]
DU2200000
Imidodicarbonimidic diamide, N-(2-phenylethyl)-, hydrochloride (1:1) [ACD/Index Name]
Insoral [Trade name]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

91XC93EU03 [DBID]
MFCD00035039 [DBID]
UNII-91XC93EU03 [DBID]
AI3-51271 [DBID]
CCRIS 4857 [DBID]
MLS000028506 [DBID]
NCGC00091940-01 [DBID]
NSC 23100 [DBID]
P7045_SIGMA [DBID]
Prestwick_615 [DBID]
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Target Organs:

      AMPK activator;Potassium Channel inhibitor TargetMol T1453

    • Therapeutical Effect:

      antidiabetic Rudolf Boehm Institute [01505983]

    • Compound Source:

      synthetic Rudolf Boehm Institute [01505983]

    • Bio Activity:

      AMPK;Potassium Channel TargetMol T1453
      Others MedChem Express HY-16397A
      Phenformin, an anti-diabetic drug, has demonstrated antitumor activity both in vitro and in vivo. MedChem Express
      Phenformin, an anti-diabetic drug, has demonstrated antitumor activity both in vitro and in vivo.; IC50 Value:; Target: Anticancer; in vitro: Treatment with phenformin significantly delayed the development of resistance to PLX4720 in cultured melanoma cells. MedChem Express HY-16397A
      PI3K/Akt/mTOR Signaling; Membrane Transporter/Ion Channel TargetMol T1453

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement